XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100

Allergies FDA Approval Drugs Protein 100

Medical Xpress

DECEMBER 2, 2022

The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine study published in Science Translational Medicine.

Allergies 80

Allergies Antibody Medicine Development 80

XTalks

NOVEMBER 4, 2020

It has long been known that mothers greatly influence the development of the growing fetus by not only providing nutrients through the placenta, but also a growing list of biological elements including beneficial antibodies, gut bacteria and now, allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Allergies 98

Allergies Antibody In-Vitro Development 98

pharmaphorum

DECEMBER 10, 2020

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Allergies 103

Allergies Vaccine Vaccination Regulation 103

Medical Xpress

APRIL 4, 2023

Children with food allergies might experience heightened anxiety over social situations involving food. A Baylor College of Medicine psychologist explains how parents can alleviate this stress while teaching them to be mindful of their allergies.

Allergies 79

Allergies Medicine 79

XTalks

JUNE 21, 2021

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance. The product is part of a three-step guidance system.

Allergies 98

Allergies Production FDA Approval Protein 98

Scienmag

APRIL 20, 2021

Babies born by caesarean section to mothers of Asian descent are eight times more likely to develop peanut allergy by age three, study shows Credit: Faculty of Medicine & Dentistry, University of Alberta Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report (..)

Allergies 86

Allergies Bacteria Medicine Development 86

Scienmag

MARCH 10, 2021

Parents of children with food allergies face significant worry, severe anxiety and post-traumatic stress – according to new research from the University of East Anglia. Between six and eight per cent of children suffer a food allergy – with eggs, milk, and peanuts being the most common causes.

Allergies 78

Allergies Research Medicine 78

Medical Xpress

APRIL 6, 2023

Black and Hispanic patients with severe allergies are less likely to get a common treatment, allergen immunotherapy, compared to white patients, according to Penn State College of Medicine researchers.

Allergies 68

Allergies Medicine Development Research 68

Scienmag

NOVEMBER 17, 2020

Credit: Eliot Herman Food allergies are a big problem. suffer from some kind of food allergy. These allergies cost a whopping $25 billion in health care each year. About 7% of children and 2% of adults in the U.S. Then there’s the time lost at school or work.

Allergies 72

Allergies Genetics Development Research 72

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 89

Allergies Trial Funding Clinical Trials Clinical Trials 89

Medical Xpress

NOVEMBER 15, 2022

Breastfed babies are believed to suffer fewer allergic conditions, like eczema and food allergies, than formula-fed babies; yet the reason has not been well understood.

Allergies 73

Allergies Development Medicine 73

Medical Xpress

FEBRUARY 28, 2023

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

Allergies 70

Allergies Clinical Trials Clinical Trials Medicine 70

Medical Xpress

FEBRUARY 16, 2023

What if an over-the-counter allergy medicine could help halt and even reverse multiple sclerosis? And if it did, could patients return to their full capacity? Those were some of the questions first posed in 2013 after a landmark discovery by UC San Francisco neuroscientist Jonah Chan, Ph.D., and physician-scientist Ari Green, MD.

Allergies 72

Allergies Scientist Medicine Drugs 72

STAT News

MARCH 13, 2023

An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. days, it estimated, she would be ready to leave her nursing home.

Allergies 145

Allergies Nurses Doctor Doctors 145

Fierce Pharma

OCTOBER 11, 2023

Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a generic version of the EpiPen allergy relief m | Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a (..)

Allergies 105

Allergies Medicine 105

World of DTC Marketing

OCTOBER 6, 2021

government $712 for the same amount of medicine or 40 times the price. Like the vast majority of medicines on the market, molnupiravir — which was originally investigated as a possible treatment for Venezuelan equine encephalitis — was developed using government funds. And while it costs $17.74 Merck charges the U.S. The Intercept.

Clinical Trials 198

Clinical Trials Clinical Trials Allergies Trials 198

Scienmag

AUGUST 14, 2020

Discovery could lead to new screening tests and potential treatments Credit: Cincinnati Children’s Two common variants in the KIF3A gene increase the risk of young children having a dysfunctional skin barrier and developing the skin condition atopic dermatitis.

Allergies 97

Allergies Gene Development Dermatology 97

Scienmag

JULY 7, 2021

Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health FOR IMMEDIATE RELEASE In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander (..)

Bacteria 97

Bacteria Allergies Medicine Dermatology 97

JAMA Internal Medicine

JULY 16, 2023

This randomized clinical trial aims to determine whether a direct oral penicillin challenge is noninferior to the standard of care of penicillin skin testing followed by an oral challenge in patients with a low-risk penicillin allergy.

Allergies 60

Allergies Clinical Trials Clinical Trials Trials 60

Scienmag

OCTOBER 5, 2020

Michael Houghton discovered hepatitis C virus and now is developing a vaccine Credit: Photo: Michael Holly Michael Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine today in recognition of his discovery of the hepatitis C (HCV) virus.

Medicine 86

Medicine Vaccine Vaccination Development 86

BioSpace

DECEMBER 4, 2020

National Institutes of Allergy and Infectious Diseases (NIAID) published a letter in The New England Journal of Medicine describing the three-month immunogenicity levels in Moderna’s mRNA-1273 vaccine. Researchers with the U.S.

Vaccine 83

Vaccine Vaccination Allergies Medicine 83

Scienmag

NOVEMBER 18, 2021

Physicians at Washington University School of Medicine in St.

Clinical Trials 86

Clinical Trials Clinical Trials Trial Funding Trials 86

Medical Xpress

DECEMBER 22, 2022

A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England Journal of Medicine.

Antibody 70

Antibody Allergies Clinical Trials Clinical Trials 70

Druggist

NOVEMBER 6, 2020

Patients commonly request over the counter medicines for a chesty cough. In today’s post, I will seek to find the best medicine for chesty cough by looking at over the counter and pharmacy-only products available in the UK. The best evidence for or against the effectiveness of medicines comes from well designed clinical trials.

Medicine 69

Medicine Containment Production Pharmacy 69

Scienmag

NOVEMBER 13, 2020

University of Cincinnati fellow presents case related to COVID-19 during national meeting Credit: Colleen Kelley/University of Cincinnati A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding (..)

Allergies 87

Allergies Dermatology Medicine 87

Scienmag

MARCH 18, 2021

Study dates emergence to as early as October 2019; simulations suggest in most cases zoonotic viruses die out naturally before causing a pandemic Credit: National Institute of Allergy and Infectious Diseases Using molecular dating tools and epidemiological simulations, researchers at University of California San Diego School of Medicine, with colleagues (..)

Allergies 81

Allergies Medicine Research 81

Scienmag

APRIL 1, 2021

Early life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens (..)

Immune Response 75

Immune Response Allergies Bacteria Development 75

Rethinking Clinical Trials

NOVEMBER 29, 2022

Gohil is an assistant professor of medicine at the University of California, Irvine, and associate medical director of epidemiology and infection prevention at UCI Health. Richard Platt, professor and chair of population medicine at the Harvard Pilgrim Health Care Institute, are the co–principal investigators for the project.

Trials 130

Trials Clinical Trials Clinical Trials Allergies 130

Pharmaceutical Technology

FEBRUARY 3, 2023

The Janssen vaccines studied in the Imbokodo and Mosaico studies were based on the mosaic concept, where they were intentionally designed to include a broader immunogen that could be used everywhere, says Dr. Mary Marovich, director of the Vaccine Research Program at National Institute of Allergy and Infectious Diseases (NIAID).

Vaccine 293

Vaccine Vaccination Antibody Trials 293

Pharmaceutical Technology

JUNE 28, 2022

grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. The Rensselaer team will partner with researchers from the Scripps Research Institute, Mount Sinai School of Medicine and the University of Bologna, Italy for this research.

Development 147

Development Bioinformatics Drugs Allergies 147

Scienmag

MAY 18, 2022

LA JOLLA, CA—The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is sponsoring a major new antiviral drug development center that will be led by Scripps Research.

Allergies 90

Allergies Research Development Drugs 90

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Production 162

Production Regulation Clinical Trials Clinical Trials 162

pharmaphorum

NOVEMBER 16, 2022

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports.

Sales 124

Sales Gene Therapy Allergies Medicine 124

Scienmag

MARCH 11, 2021

“Phage” therapies offer potential strategy to combat antibacterial resistance Credit: NIAID The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy.

Research 92

Research Allergies Medicine 92

Medical Xpress

FEBRUARY 7, 2023

In a new review article, Johns Hopkins Medicine experts and collaborators across the U.S. emphasize that climate change—particularly global warming—is contributing to an increase in the rates and to greater severity of nasal and sinus diseases, such as seasonal allergies—conditions that affect 2 billion people worldwide.

Allergies 63

Allergies Medicine 63

Pharmaceutical Technology

AUGUST 5, 2022

It is ultra-rare,” says Jesús Rodriguez Requena, PhD, associate professor in the Department of Medicine at the University of Santiago de Compostela. There is an enormous emphasis on prion protein and prion protein folding,” says Dr. Laura Manuelidis, professor of neuropathology at the Yale School of Medicine. “If

Drugs 299

Drugs Protein Vaccine Vaccination 299